Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Immunological Investigations|May 16, 2006
Sphingosine kinase and sphingosine-1-phosphate regulate migration, endocytosis and apoptosis of dendritic cellsS Eigenbrod, R Derwand, V Jakl, et al.
Biochemical and Biophysical Research Communications|October 15, 1993
Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cellsA Eigler, B Sinha, S Endres
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1995
Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7A Eigler, J Moeller, S Endres
Immunology Today|November 14, 1997
Taming TNF: strategies to restrain this proinflammatory cytokineA Eigler, B Sinha, G Hartmann, et al.
European Journal of Immunology|January 1, 1995
Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoidsB Sinha, J Semmler, T Eisenhut, et al.
International Journal of Immunopharmacology|August 26, 1998
Adrenaline enhances LPS-induced IL-10 synthesis: evidence for protein kinase A-mediated pathwayB Siegmund, A Eigler, G Hartmann, et al.
Cytokines, Cellular & Molecular Therapy|September 18, 1998
Cytokines and therapeutic oligonucleotidesG Hartmann, M Bidlingmaier, A Eigler, et al.
International Journal of Immunopharmacology|July 1, 1995
The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediators TNF-alpha and nitric oxideT F Greten, A Eigler, B Sinha, et al.
European Journal of Pharmacology|March 28, 1996
Cicaprost and the type IV phosphodiesterase inhibitor, rolipram, synergize in suppression of tumor necrosis factor-alpha synthesisT F Greten, B Sinha, C Haslberger, et al.
European Journal of Gastroenterology & Hepatology|July 1, 1996
Synthesis of tumour necrosis factor-alpha in tissue culture of rat caecum: lack of suppression by phosphodiesterase inhibitors and prostanoidsT F Greten, J Moeller, H Feldmeier, et al.
Pageof 14